CVI Holdings’s Dare Bioscience DARE Stock Holding History

CVI Holdings’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-39,305	Closed	-$395K	–	56
2018 Q1	$395K	Buy	+39,305	New	+$795K	0.54%	22

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

CVI Holdings's DARE Position: Q2 2018 in Review

CVI Holdings sold out of Dare Bioscience (DARE) in Q2 2018, closing a stake of 39,305 shares — an estimated $395K sold.

CVI Holdings first reported a position in DARE in Q1 2018 and held it in 1 quarter. The position peaked at $395K in Q1 2018. 15 funds tracked by Wall St. Rank hold DARE as of Q2 2018.

CVI Holdings reported no remaining Dare Bioscience position as of Q2 2018 after selling out during the quarter.
CVI Holdings sold 39,305 Dare Bioscience shares in Q2 2018, an estimated $395K.
CVI Holdings first reported a position in Dare Bioscience in Q1 2018 and held it in 1 quarter.
CVI Holdings's Dare Bioscience position peaked at $395K in Q1 2018.
15 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2018.

Based on CVI Holdings's 13F filing for Q2 2018, filed 14 Aug 2018.